Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Auto and PSU stocks lead among losers
Thu, 13 Jun 01:30 pm

Backed by persistent selling activity Indian equity markets continued to trade in the red during the post noon trading session. Barring stocks from consumer durables, all the sectoral indices are trading in the red with Auto and PSU stocks leading the pack of losers.

BSE-Sensex is down by 180 points and NSE-Nifty is trading down by 49 points. While BSE Mid Cap is trading down by 1.06%, BSE Small Cap index is trading up by 0.82%. The rupee is trading at 58.38 to the US dollar.

Most of the Indian pharma stocks are trading in the red with Aaurobindo Pharma and Dishman being among the major losers. As per a leading financial daily, Sun Pharmaceuticals has sued Novartis in the US court, in order to launch Novartis' brand Gleevec (Imatinib Mesylate active ingredient of Gleevec) before patent expiry. The complaint filed by Sun challenges validity of patent expiring in 2019. Sun Pharma had informed Novartis about its Para IV filed for Gleevec for 2016 patents, at this time 2019 patent was not listed. Reportedly, Novartis did not sue Sun Pharma in the required time frame of 45-days. Sun is believed to be the FTF (first to file) for this drug. Gleevec contributes approximately US$ 4.7 bn to Novartis' revenues. Sun Pharma was trading down by 3%.

Most of the FMCG stocks are trading in the red with Colgate and Godrej Consumer being among the major losers. As per a leading financial daily, Hindustan Unilever (HUL) will enter the hair colour segment through its new brand TIGI. Apart from that, the company will also be launching other TIGI products such as gel, shampoo, wax and mousse under Bead Head and S-Factor brands. Unilever acquired TIGI's professional hair products business in 2009. Reportedly TIGI's products fall in the super premium category which are more expensive than existing premium brands such as Dove, Wella and Scwarzkopf. To begin with, HUL plans to sell TIGI's products through just over 40 salons in the country. HUL stock is trading marginally down.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Auto and PSU stocks lead among losers". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.